HNF1A and HNF4A mutations are associated with prolonged half-life of glibenclamide but not glipizide in human MODY subjects

被引：0
|
作者：
Urbanova, J. [1 ,2 ]
Andel, M. [1 ,2 ]
机构：
[1] Ctr Res Diabet Metab & Nutr, Dept Internal Med 2, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
来源：
DIABETOLOGIA | 2014年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
810
引用
收藏
页码：S327 / S327
页数：1
相关论文
共 50 条
  • [41] Exploring the role of transcription factors HNF1A, HNF1B, and HNF4A in human induced pluripotent stem cell-derived pancreatic islet cell differentiation
    Unger, L.
    Friestad, A.
    Legoy, T. A.
    Ghila, L. M.
    Chera, S.
    DIABETOLOGIA, 2023, 66 (SUPPL 1) : S97 - S97
  • [42] Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations
    Ben Khelifa, S.
    Martinez, R.
    Dandana, A.
    Khochtali, I.
    Ferchichi, S.
    Castano, L.
    GENE, 2018, 651 : 44 - 48
  • [43] Transcription Factors HNF1A, HNF4A, and FOXA2 Regulate Hepatic Cell Protein N-Glycosylation
    Bockor, Vedrana Vicic
    Foglar, Nika
    Josipovic, Goran
    Klasic, Marija
    Vujic, Ana
    Plavsa, Branimir
    Keser, Toma
    Smajlovic, Samira
    Vojta, Aleksandar
    Zoldos, Vlatka
    ENGINEERING, 2024, 32 : 57 - 68
  • [44] Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth
    Pihoker, Catherine
    Gilliam, Lisa K.
    Ellard, Sian
    Dabelea, Dana
    Davis, Cralen
    Dolan, Lawrence M.
    Greenbaum, Carla J.
    Imperatore, Giuseppina
    Lawrence, Jean M.
    Marcovina, Santica M.
    Mayer-Davis, Elizabeth
    Rodriguez, Beatriz L.
    Steck, Andrea K.
    Williams, Desmond E.
    Hattersley, Andrew T.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2013, 98 (10): : 4055 - 4062
  • [45] IL6, IL6-INDUCED MIRNAS AND HNF1A/HNF4A AND THE EPIGENETIC CONTROL OF CCCDNA TRANSCRIPTION
    Scisciani, C.
    Pediconi, N.
    Palumbo, A.
    Lucifora, J.
    Guerrieri, F.
    Rose-John, S.
    Protzer, U.
    Levrero, M.
    Belloni, L.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S18 - S18
  • [46] HNF1A POU Domain Mutations Found in Japanese Liver Cancer Patients Cause Downregulation of HNF4A Promoter Activity with Possible Disruption in Transcription Networks
    Haque, Effi
    Teeli, Aamir Salam
    Winiarczyk, Dawid
    Taguchi, Masahiko
    Sakuraba, Shun
    Kono, Hidetoshi
    Leszczynski, Pawel
    Pierzchala, Mariusz
    Taniguchi, Hiroaki
    GENES, 2022, 13 (03)
  • [47] Functional Analysis of a Novel HNF4A Variant Identified in a Patient With MODY1
    Morikawa, Shuntaro
    Ko, Hui Ling
    Ren, Ee Chee
    Hara, Kazuya
    Kaneko, Naoya
    Hishimura, Nozomi
    Nakamura, Akie
    Manabe, Atsushi
    JOURNAL OF THE ENDOCRINE SOCIETY, 2024, 8 (06)
  • [48] Prevalence of HNF1A (MODY3) mutations in a Norwegian population (the HUNT2 Study)
    Eide, S. A.
    Raeder, H.
    Johansson, S.
    Midthjell, K.
    Sovik, O.
    Njolstad, P. R.
    Molven, A.
    DIABETIC MEDICINE, 2008, 25 (07) : 775 - 781
  • [49] Spectrum of HNF1A and GCK mutations in Canadian families with maturity-onset diabetes of the young (MODY)
    McKinney, JL
    Cao, HN
    Robinson, JF
    Metzger, DL
    Riddell, DC
    Sanderson, SR
    Pacaud, D
    Ho, J
    Hegele, RA
    CLINICAL AND INVESTIGATIVE MEDICINE, 2004, 27 (03): : 135 - 141
  • [50] Evaluation in Monogenic Diabetes of the Impact of GCK, HNF1A, and HNF4A Variants on Splicing through the Combined Use of In Silico Tools and Minigene Assays
    Bouvet, Delphine
    Blondel, Amelie
    Agathe, Jean-Madeleine de Sainte
    Leroy, Gwendoline
    Saint-Martin, Cecile
    Bellanne-Chantelot, Christine
    HUMAN MUTATION, 2023, 2023
12345